Stone X Group Inc. Astrazeneca PLC Transaction History

Stone X Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$55.72 - $67.12 $211,680 - $254,988	-3,799 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $205,221 - $242,490	3,799 New	3,799 $221,000
Q3 2021 Oct 20, 2021	SELL	$55.56 - $60.79 $1.94 Million - $2.13 Million	-35,005 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $1.69 Million - $2.11 Million	35,005 New	35,005 $2.1 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $942,619 - $1.11 Million	-32,549 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	32,549	32,549 $1.11 Million

1,358

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.